Filing Details
- Accession Number:
- 0000919574-19-003096
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-02 16:47:18
- Reporting Period:
- 2019-04-30
- Accepted Time:
- 2019-05-02 16:47:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1404281 | Novus Therapeutics Inc. | NVUS | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1734312 | Lifesci Index Partners Llc | 250 West 55Th Street 16Th Floor New York NY 10019 | No | No | Yes | No | |
| 1735029 | Paul Yook | C/O Lifesci Venture Gp, Llc 250 West 55Th Street, 16Th Floor New York NY 10019 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.01 Per Share | Disposition | 2019-04-30 | 200 | $2.70 | 1,065,867 | No | 4 | S | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See Footnote |
Footnotes
- The Common Stock is held in the accounts of private investment funds managed by LifeSci Index Partners LLC and may be deemed to be beneficially owned by Paul Yook, a principal of LifeSci Index Partners LLC. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and affirmatively disclaims being a "group" for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.
Billionaire Hedge Funds
